Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;50(1-2):180-93.
doi: 10.1111/j.1469-7610.2008.02062.x.

Psychopharmacology: concepts and opinions about the use of stimulant medications

James M Swanson  1 , Nora D Volkow
Affiliations
Review

Psychopharmacology: concepts and opinions about the use of stimulant medications

James M Swanson et al. J Child Psychol Psychiatry. 2009 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: James M. Swanson has received honoraria for lectures from J & J Jassen-Ortho, Inc., UCB Pharma Ltd and Convention Likage Inc., and consulting fees from NV Organon.

Figures

Figure 1
Figure 1
Estimates of Prescriptions for IR and CR MPH and AMP in the USA
Figure 2
Figure 2
Funnel Plot of Effects from Studies of DAT Density in ADHD (The references for studies 1 to 12 are provided in Volkow et al., 2007a)
Figure 3
Figure 3
UN Supply Estimates (combined DDD for MPH and AMP) for UK and USA
Figure 4
Figure 4
Estimates of Supply and Prescriptions in the USA from International Narcotics Control Board (1999–2006) and Veripan(R)-One National.
See this image and copyright information in PMC

Comment in

References

    1. Adesman A. Flawed attention-deficit/hyperactivity disorder medication comparison. Pediatrics. 2004;114:1132. - PubMed
    1. Angell M. Industry sponsored research: A broken system. Journal of the American Medical Association. 2008;300:1069–1071. - PubMed
    1. Arnold LE, Swanson JM, Hectman L, Vitiello B, Molina BSG, Jensen P, Hinshaw SP, Wigal T. Understanding the 36-month MTA follow-up findings in context. Attention. 2008;15:14–18.
    1. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. European Child and Adolescent Psychiatry. 2006;15:476–495. - PubMed
    1. Barkley RA. A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry. 1977;18:137–165. - PubMed

MeSH terms

Substances